-transparent.png){kind=logo}
Renal plasma flow (RPF), glomerular filtration rate (GFR), arginine vasopressin in plasma (AVP), free water clearance (CH2O) and blood pressure (BP) were determined in 11 patients with essential hypertension at the end of 3 consecutive periods of observation each of 6 of weeks duration; indapamide 2.5 mg daily was given in period 2 and placebo in periods 1 and 3. RPF and GFR were reduced by 9% and BP by 9%/14% supine and 14%/12% standing during indapamide treatment. Changes in renal haemodynamics were not correlated with those in BP. AVP was not significantly altered by indapamide and was not correlated with BP. Indapamide reduced CH2O possibly due to the reduction in GFR. It is concluded that indapamide evidently induces redistribution of the cardiac output, with enhanced muscle blood flow and reduced renal perfusion, and that AVP does not seem to be involved in blood pressure regulation in mild to moderate essential hypertension under basal conditions.
E B Pedersen, and
H Danielsen, and
E S Spencer
May 1976,
Scandinavian journal of clinical and laboratory investigation,
E B Pedersen, and
H Danielsen, and
E S Spencer
October 1984,
Postgraduate medical journal,
E B Pedersen, and
H Danielsen, and
E S Spencer
March 1956,
Acta endocrinologica,
E B Pedersen, and
H Danielsen, and
E S Spencer
November 1975,
Acta medica Scandinavica,
E B Pedersen, and
H Danielsen, and
E S Spencer
January 1988,
Blood purification,
E B Pedersen, and
H Danielsen, and
E S Spencer
April 1961,
The American journal of physiology,
E B Pedersen, and
H Danielsen, and
E S Spencer
September 1995,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
E B Pedersen, and
H Danielsen, and
E S Spencer
July 1992,
European journal of vascular surgery,
E B Pedersen, and
H Danielsen, and
E S Spencer
May 1962,
The New physician,
E B Pedersen, and
H Danielsen, and
E S Spencer
November 2004,
Kidney international. Supplement,
